1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
In Vitro Diagnostics/IVD Market by Product, Technology, Application - Forecast to 2021

In Vitro Diagnostics/IVD Market: Forecast until 2021

  • December 2016
  • 304 pages
  • ID: 4436645
In this report:
The U.K. had a share of ##.##% of the IVD market in Europe in 2015, and it is expected to grow to USD ##,##.## million by 2021 from USD ##,##.## million in 2016 at a CAGR of ##.##%, driven by the rapidly aging population, growing number of infectious diseases, increasing demand for personalized medicine, and rising acceptance of point-of-care diagnostics and patient self-testing practices.


Table of Contents

Search Inside

The overall IVD market is estimated to grow ~$78.7B by 2021, at a compound annual growth rate of 5.50 percent during the forecast period of 2016 to 2021. Increase in this sector is mainly driven by the growing prevalence of diseases including diabetes, cardiovascular diseases, and across the world and shift in focus from centralized laboratories to decentralized point-of-care testing is also support the rise of the IVD market.

In this business report, the overall IVD market is split by products & services, technology, application, final user, and area. Established on technology, the IVD market is primarily divided into immunoassays/immunochemistry, clinical chemistry, molecular diagnostics, hematology, clinical microbiology, coagulation & hemostasis, and other technologies. The immunoassays/immunochemistry segment recorded for the biggest share of the IVD market in 2015. The increasing preference for these technologies in clinical diagnostics over conventional methods and the ability of immunoassay/immunochemistry technologies to offer faster results with high sensitivity and accuracy are contributing to the increase of immunoassays/immunochemistry market during projection period.

Established on application, the sector is divided into diabetes, infectious diseases, oncology/cancer, cardiology, HIV/AIDS, autoimmune diseases, nephrology, drug testing/pharmacogenomics, and other applications. In 2015, the infectious diseases segment recorded for the most important share of the IVD market. The oncology/cancer segment is projected to register the highest compound annual growth rate (CAGR) during the forecast period due to the increasing incidence of cancer forms that stimulates the industry demand for early detection of the disease.

In 2015, North America continent commanded the biggest share of the IVD market, succeeded by Europe (EU). The U.S.A is a prime market for IVD due to the growing acceptance of point-of-care diagnostics and patient self-testing practices in the area. The APAC market is anticipated to witness the highest increase in the next years primarily due to the increasing focus of manufacturers on this area.

Top actors in the overall IVD market are Roche Diagnostics, Abbott Laboratories (NYSE:ABT), Siemens Healthineers, Danaher (NYSE:DHR), Thermo Fisher Scientific (NYSE:TMO), Sysmex Corporation, BioRad (NYSE:BIO), bioMérieux, Becton Dickinson (NYSE:BDX), Becton, Dickinson and Company (BD) (NYSE:BDX), Johnson and Johnson, Ortho-Clinical Diagnostics, Incorporated, Qiagen N.V., and Diasorin S.P.A..

Segment Research

• Detailed insights on all the submarkets, established on technology (immunoassays/immunochemistry, clinical chemistry, molecular diagnostics, hematology, clinical microbiology, coagulation & hemostasis, and other technologies), this can benefit industry actors to distinguish high development segments in the IVD market.

• The report also offers info on top players in this industry and their increase strategies and latest developments. This can benefit the company to assess the competition at overall and regional levels in a better manner.

• Key insights and market sizing for the distinct end users of the IVD market that is, hospitals, laboratories, academic institutes, point-of-care testing, patient self-testing, and other end users.

• Country-wise market size and estimate for all the sub segments. Therefore, not only the high increase products & services, technology, application, and end user areas; the market size numbers provided in the industry report will also enable market actors to recognize top geographic industries, and thereby strategize overall marketing efforts in order to accomplish sustainable revenue increase in the next years.

• It offers key aspects on market forces, including drivers, market restraints, alternatives, and opportunities for this sector.

Reasons to Buy the Report

The study will increase established companies as well as new entrants/smaller companies to measure the pulse of the sector, which in turn would benefit them collect a larger market share. Companies obtaining the analysis could use one or an aggregation of the below-mentioned five strategies for rising their market shares.

This industry report offers business insights on these pointers:

• Market Uptake: Exhaustive data on the product types provided by key players in the IVD market. The market research examines the sector by product class across all areas

• Product Development/Innovative products: In-depth understanding on upcoming trends, Research&development activities, and recent product launches in the IVD market

• Market Development: Highlighted information on profitable emerging sectors, established on products & services, technology, application, end-user, and area

• industry diversification: Complete information about recent products, increasing regions, recent evolutions, and market investments in the IVD market

• opposing assessment: Detailed assessment of market shares, increase strategies, products, distribution networks, and manufacturing competences of key players in the IVD market

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Lateral Flow Assay Market by Product, Application, Veterinary, Drug Development, Food Safety), Technique, End User - Global Forecast to 2022

Lateral Flow Assay Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • August 2017
  • by MarketsandMarkets

“The global lateral flow assay market projected to grow at a CAGR of 8.2%.”The global lateral flow assay market is projected to reach USD 8.24 billion by 2022, growing at a CAGR of 8.2% from 2017 to ...

Global POC Blood Glucose Monitoring Devices Market 2017-2021

POC Blood Glucose Monitoring Devices Sector: Worldwide Forecast until 2021

  • $ 3500
  • Industry report
  • September 2017
  • by Infiniti Research Limited

About POC Blood Glucose Monitoring DevicesPOC blood glucose monitoring devices are portable, near-patient devices that allow the immediate detection of glucose levels in a patient and facilitate rapid ...

Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

  • $ 4000
  • Industry report
  • October 2017
  • by GlobalData

Clinical Chemistry Rapid Tests & Point-of-Care (POC) Diagnostic Tests - Medical Devices Pipeline Assessment, 2017SummaryGlobalData’s Medical Devices sector report, “Clinical Chemistry Rapid Tests & ...


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.